tradingkey.logo
搜索

Inspire Medical Systems Inc

INSP
添加自选
50.210USD
+0.135+0.27%
收盘 07-31 16:00美东报价延迟15分钟
1.45B总市值
11.26市盈率 TTM

Inspire Medical Systems Inc

50.210
+0.135+0.27%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.27%

5天

+2.07%

1月

+6.94%

6月

-31.64%

今年开始到现在

-45.56%

1年

-60.18%

关键数据
49.920今开
50.390最高
672.28K成交量
11.26市盈率 TTM
37.08市盈率动
--股息TTM
2.33%换手率
50.020昨收
49.020最低
16.09M成交额
27.03市盈率静
1.83市净率
0.00%股息率 TTM
15.97%ROA
147.03052周最高
0.78量比
53.51M净利润
28.80M总股本
4.4573每股收益TTM
0.76Beta
18.37%ROE
39.61052周最低
2.74%振幅
86.47%毛利率
1.45B总市值
0.34回报/风险
3.36%风险率

TradingKey Inspire Medical Systems Inc股票评分

单位: USD 更新时间: 2026-07-31

操作建议

Inspire Medical Systems Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名94/199位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价61.40。中期看,股价处于平稳状态。近一个月,市场表现一般,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Inspire Medical Systems Inc评分

相关信息

行业排名
94 / 199
全市场排名
189 / 4281
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
极度看空

Inspire Medical Systems Inc亮点

亮点风险
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
业绩高增长
公司营业收入稳步增长,连续3年增长45.96%
估值合理
公司最新PE估值11.26,处于3年历史合理位
机构减仓
最新机构持股34.93M股,环比减少15.55%
约翰·胡斯曼持仓
明星投资者约翰·胡斯曼持仓,最新持仓市值12.83K
活跃度降低
近期活跃度降低,过去20天平均换手率-0.03

分析师目标

根据 18 位分析师
持有
评级
61.400
目标均价
+22.29%
涨幅空间

Inspire Medical Systems Inc新闻

即将为您带来更多新闻,敬请期待。。。

收益预测

分析师评级

根据 18 位分析师
持有
评级
61.400
目标均价
+22.29%
涨幅空间
强力买入
买入
持有
卖出
强力卖出

同行比较

109
总数
7
中位数
9
平均值
公司名称
评级分布
分析师数
Inspire Medical Systems Inc
INSP
18
美敦力
MDT
34
Dexcom Inc
DXCM
32
史赛克
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
雅培
ABT
29
1
2
3
...
22

技术指标

技术指标
卖出(3)
中性(4)
买入(0)
指标
数值
方向
MACD(12,26,9)
-0.638
中性
RSI(14)
53.309
中性
STOCH(KDJ)(9,3,3)
41.130
中性
ATR(14)
2.409
低波动
CCI(14)
-77.514
中性
Williams %R
62.193
卖出
TRIX(12,20)
0.506
卖出
StochRSI(14)
8.526
卖出
移动平均线
卖出(4)
中性(0)
买入(2)
指标
数值
方向
MA5
50.840
卖出
MA10
51.036
卖出
MA20
50.781
卖出
MA50
45.949
买入
MA100
49.218
买入
MA200
68.772
卖出

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Inspire Medical Systems Inc简介

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
公司代码INSP
公司Inspire Medical Systems Inc
CEOHerbert (Timothy P)
网址https://www.inspiresleep.com/

公司股东

持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
11.06%
Wellington Management Company, LLP
7.67%
Vanguard Portfolio Management, LLC
5.68%
Deerfield Management Company, L.P.
5.23%
Vanguard Capital Management, LLC
4.40%
其他
65.96%

常见问题

Inspire Medical Systems Inc(INSP)的当前股价是多少?

Inspire Medical Systems Inc(INSP)的当前股价是 50.21。

Inspire Medical Systems Inc的股票代码是什么?

Inspire Medical Systems Inc的股票代码是INSP。

Inspire Medical Systems Inc股票的52周最高点是多少?

Inspire Medical Systems Inc股票的52周最高点是147.03。

Inspire Medical Systems Inc股票的52周最低点是多少?

Inspire Medical Systems Inc股票的52周最低点是39.61。

Inspire Medical Systems Inc的市值是多少?

Inspire Medical Systems Inc的市值是1.45B。

现在Inspire Medical Systems Inc(INSP)的股票是买入、持有还是卖出?

根据分析师评级,Inspire Medical Systems Inc(INSP)的总体评级为signal_hold,目标价格为61.40。

Inspire Medical Systems Inc(INSP)股票的每股收益(EPS TTM)是多少

Inspire Medical Systems Inc(INSP)股票的每股收益(EPS TTM)是4.95。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有